Related Experiment Videos
Clinical immunity after neonatal rotavirus infection. A prospective longitudinal study in young children
Insights
Neonatal rotavirus infection in infants does not prevent reinfection but significantly reduces the severity of subsequent rotavirus illness. This finding highlights a protective effect against severe disease in early life rotavirus exposure.
Area of Science:
- Pediatrics
- Infectious Diseases
- Immunology
Background:
- Rotavirus is a leading cause of gastroenteritis in infants worldwide.
- The impact of neonatal rotavirus infection on subsequent immunity and disease severity is not fully understood.
Purpose of the Study:
- To investigate whether rotavirus infection in newborn infants confers immunity against postneonatal rotavirus infection.
- To assess the clinical outcomes and severity of rotavirus infections in relation to prior neonatal infection.
Main Methods:
- A longitudinal study of 81 infants from birth for three years.
- Clinical and serologic monitoring for rotavirus infection and symptoms.
- Comparison of infection rates and symptom severity between infants with and without neonatal rotavirus infection.
Main Results:
- No significant difference in the rate of rotavirus infection during the three-year follow-up between infants with and without neonatal infection.
- Infants with prior neonatal rotavirus infection experienced significantly less frequent and less severe symptoms during postneonatal infections (P = 0.003).
- 38% of infants with neonatal infection had mild to moderate symptoms during the first postneonatal infection, versus 85% of those without neonatal infection (mild, moderate, or severe).
Conclusions:
- Neonatal rotavirus infection does not confer sterilizing immunity against reinfection.
- Neonatal rotavirus infection provides significant protection against the development of clinically severe rotavirus disease during subsequent infections.
- Early-life rotavirus exposure may prime the immune system to mitigate severe illness upon re-exposure.
Abstract:
To determine whether rotavirus infection in newborn babies conferred immunity to postneonatal rotavirus infection, we studied 81 babies at birth and kept them under clinical and serologic study for three years. During the first 14 days of life, 44 of the infants excreted rotavirus, and 37 did not. Fifty-five per cent of those with neonatal infection and 54 per cent of those without it had rotavirus infection during the next three years. Symptoms associated with postneonatal rotavirus infection were significantly less frequent and less severe in the infants who had had neonatal infection (P = 0.003) than in those who had not. Thirty-eight per cent of the former group (9 of 24 infants) had symptoms of mild (3 infants) or moderate (6) severity during the first postneonatal infection. In contrast, 85 per cent of the latter group (17 of 20 infants) had mild (3), moderate (6), or severe (8) symptoms. We conclude that neonatal rotavirus infection does not confer immunity against reinfection but does protect against the development of clinically severe disease during reinfection.